From: Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital
Treatment | HCAP (n= 231) | CAP (n= 296) | P-value |
---|---|---|---|
Inappropriate antibiotic therapy b | 27/73 (37.0) | 19/78 (24.4) | 0.092 |
Monotherapy | 30 (13.0) | 53 (17.9) | 0.124 |
   Amino-penicillins | 3 (1.3) | 5 (1.7) | - |
   Cephalosporin | 5 (2.2) | 8 (2.7) | - |
   Antipseudomonal penicillins | 6 (2.6) | 6 (2.0) | - |
   Fluroquinolone | 13 (5.6) | 34 (11.5) | - |
   Carbapenem | 3 (1.3) | 0 (0) | - |
Combination therapy | 201 (87.0) | 243 (82.1) | 0.124 |
   β-lactams + fluoroquinolone | 4 (1.7) | 8 (2.7) | - |
   β-lactams + macrolide | 36 (15.6) | 112 (37.8) | <0.001 |
   β-lactams + clindamycin | 10 (4.3) | 14 (4.7) | - |
   β-lactams + aminoglycoside | 6 (2.6) | 1 (0.3) | - |
   Fluoroquinolone + clindamycin | 13 (5.6) | 12 (4.1) | - |
   Antipseudomonal β-lactams + fluroquinolone | 63 (27.3) | 48 (16.2) | 0.001 |
   Antipseudomonal β-lactams + macrolide | 0 (0) | 1 (0.3) | - |
   Antipseudomonal β-lactams + clindamycin | 6 (2.6) | 3 (1.0) | - |
   Antipseudomonal β-lactams + aminoglycoside | 8 (3.5) | 2 (0.7) | - |
   Other combination therapyc | 55 (23.8) | 42 (14.2) | 0.002 |
Clinical outcomes | Â | Â | Â |
   In-hospital mortality | 65 (28.1) | 32 (10.8) | <0.001 |
   Early treatment failured | 56 (24.2) | 37 (12.5) | <0.001 |
   ICU admission | 49 (21.2) | 37 (12.5) | 0.007 |
   ICU mortality | 31 (13.4) | 21 (7.1) | 0.016 |
   Need for mechanical ventilation | 47 (20.3) | 39 (13.2) | 0.027 |
   Duration of hospital stay (days) | 18.6 ± 19.1 | 12.9 ± 13.1 | <0.001 |